0000899243-20-003032.txt : 20200204
0000899243-20-003032.hdr.sgml : 20200204
20200204204757
ACCESSION NUMBER: 0000899243-20-003032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200201
FILED AS OF DATE: 20200204
DATE AS OF CHANGE: 20200204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lehrer-Graiwer Joshua
CENTRAL INDEX KEY: 0001789673
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 20576050
MAIL ADDRESS:
STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC.
STREET 2: 171 OYSTER POINT BLVD., SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 171 OYSTER POINT BLVD, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-01
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001789673
Lehrer-Graiwer Joshua
C/O GLOBAL BLOOD THERAPEUTICS, INC.
171 OYSTER POINT BLVD., SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2020-01-31
5
A
0
E
579
36.68
A
2595
D
Common Stock
2020-02-01
4
M
0
6100
A
8695
D
Common Stock
2020-02-01
4
F
0
2163
65.26
D
6532
D
Common Stock
2020-02-03
4
M
0
2188
48.44
A
8720
D
Common Stock
2020-02-03
4
S
0
2188
62.81
D
6532
D
Common Stock
2020-02-03
4
M
0
1657
59.60
A
8189
D
Common Stock
2020-02-03
4
S
0
1657
65.00
D
6532
D
Restricted Stock Units
2020-02-01
4
M
0
1037
0.00
D
Common Stock
1037
3113
D
Restricted Stock Units
2020-02-01
4
M
0
2125
0.00
D
Common Stock
2125
8500
D
Restricted Stock Units
2020-02-01
4
M
0
2938
0.00
D
Common Stock
2938
17625
D
Stock Option (Right to Buy)
59.60
2020-02-03
4
M
0
1657
0.00
D
2028-01-31
Common Stock
1657
13250
D
Stock Option (Right to Buy)
48.44
2020-02-03
4
M
0
2188
0.00
D
2029-01-31
Common Stock
2188
26250
D
Restricted Stock Units
2020-02-03
4
A
0
24160
0.00
A
Common Stock
24160
24160
D
Stock Option (Right to Buy)
65.82
2020-02-03
4
A
0
38500
0.00
A
2030-02-02
Common Stock
38500
38500
D
Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 6,100 shares of Common Stock underlying the Reporting Person's RSUs.
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from August 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The shares of Common Stock underlying the option vest in 16 equal quarterly installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
/s/ Lesley Ann Calhoun, Attorney-in-Fact
2020-02-04